Matrix metalloproteinase-2 and mesangiolysis in diabetic nephropathy

被引：2
|
作者：
Kanauchi, M [1 ]
Nishioka, H [1 ]
Kawano, T [1 ]
Uyama, H [1 ]
Shiiki, H [1 ]
Dohi, K [1 ]
机构：
[1] Nara Med Univ, Dept Internal Med 1, Nara, Japan
来源：
NEPHRON | 1999年 / 83卷 / 02期
关键词：
D O I：
10.1159/000045501
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：174 / 175
页数：2
相关论文
共 50 条
  • [1] An imbalance between matrix metalloproteinase-2 and tissue inhibitor of matrix metalloproteinase-2 contributes to the development of early diabetic nephropathy
    Han, Sang Youb
    Jee, Yi Hwa
    Han, Kum Hyun
    Kang, Young Sun
    Kim, Hyoung Kyu
    Han, Jee Young
    Kim, Young Sik
    Cha, Dae Ryong
    [J]. NEPHROLOGY DIALYSIS TRANSPLANTATION, 2006, 21 (09) : 2406 - 2416
  • [2] Association of matrix metalloproteinase-2 gene variants with diabetic nephropathy risk
    Sarray, Sameh
    Lamine, Laila Ben
    Dallel, Meriem
    Ezzidi, Intissar
    Sellami, Nejla
    Turki, Amira
    Moustafa, Amgad Elbaz El-Agroudy
    Mtiraoui, Nabil
    [J]. JOURNAL OF GENE MEDICINE, 2023, 25 (11):
  • [3] Experimental diabetic nephropathy is accelerated in matrix metalloproteinase-2 knockout mice
    Takamiya, Yoshimi
    Fukami, Kei
    Yamagishi, Sho-ichi
    Kaida, Yusuke
    Nakayama, Yosuke
    Obara, Nana
    Iwatani, Ryuji
    Ando, Ryotaro
    Koike, Kiyomi
    Matsui, Takanori
    Nishino, Yuri
    Ueda, Seiji
    Cooper, Mark E.
    Okuda, Seiya
    [J]. NEPHROLOGY DIALYSIS TRANSPLANTATION, 2013, 28 (01) : 55 - 62
  • [4] Urine matrix metalloproteinase-2,-8 and-9 activities in type 2 diabetic nephropathy
    van der Zijl, N. J.
    Hanemaaijer, R.
    Tushuizen, M. E.
    Schindhelm, R. K.
    Boerop, J.
    Rustemeijer, C.
    Bilo, H. J.
    Verheijen, J. H.
    Diamant, M.
    [J]. DIABETOLOGIA, 2008, 51 : S486 - S487
  • [5] Urinary matrix metalloproteinase-2,-8 and-9 activities in type 2 diabetic nephropathy
    Tushuizen, M
    Hanemaaijer, R
    Van Der Zijl, N
    Van Lent, N
    Rustemeijer, C
    Bilo, HJ
    Verheijen, JH
    Adiamant, M
    [J]. DIABETES, 2005, 54 : A202 - A202
  • [6] Enhanced expression of two discrete isoforms of matrix metalloproteinase-2 in experimental and human diabetic nephropathy
    Kim, Sang Soo
    Shin, Nari
    Bae, Sun Sik
    Lee, Min Young
    Rhee, Harin
    Kim, Il Young
    Seong, Eun Young
    Lee, Dong Won
    Lee, Soo Bong
    Kwak, Ihm Soo
    Lovett, David H.
    Song, Sang Heon
    [J]. PLOS ONE, 2017, 12 (02):
  • [7] Role of matrix metalloproteinase-2 isoforms in diabetic heart
    Lee, H. W.
    Lee, S. J.
    Lee, M. Y.
    Song, S. H.
    Ahn, J. H.
    Park, J. S.
    Oh, J. H.
    Choi, J. H.
    Lee, H. C.
    Cha, K. S.
    Hong, T. J.
    Park, M. H.
    [J]. EUROPEAN JOURNAL OF HEART FAILURE, 2017, 19 : 593 - 593
  • [8] MATRIX METALLOPROTEINASE-2 IS ASSOCIATED WITH OXIDATIVE STRESS IN PATIENTS WITH EARLY STAGES OF TYPE II DIABETIC NEPHROPATHY
    Dimas, Grigorios G.
    Iliadis, Fotios S.
    Tegos, Thomas J.
    Spiroglou, Sofia G.
    Pitsalidis, Christos G.
    Karamouzis, Ioannis M.
    Didaggelos, Triantafyllos P.
    Adamidou, Alexandra P.
    Savopoulos, Christos G.
    Karamouzis, Michael I.
    Orologas, Anastasios G.
    Hatzitolios, Apostolos I.
    Grekas, Dimitrios M.
    [J]. NEPHROLOGY DIALYSIS TRANSPLANTATION, 2013, 28 : 162 - 162
  • [9] Ramipril inhibits AGE-RAGE-induced matrix metalloproteinase-2 activation in experimental diabetic nephropathy
    Fukami, Kei
    Yamagishi, Sho-ichi
    Coughlan, Melinda T
    Harcourt, Brooke E
    Kantharidis, Phillip
    Thallas-Bonke, Vicki
    Okuda, Seiya
    Cooper, Mark E
    Forbes, Josephine M
    [J]. DIABETOLOGY & METABOLIC SYNDROME, 2014, 6
  • [10] Ramipril inhibits AGE-RAGE-induced matrix metalloproteinase-2 activation in experimental diabetic nephropathy
    Kei Fukami
    Sho-ichi Yamagishi
    Melinda T Coughlan
    Brooke E Harcourt
    Phillip Kantharidis
    Vicki Thallas-Bonke
    Seiya Okuda
    Mark E Cooper
    Josephine M Forbes
    [J]. Diabetology & Metabolic Syndrome, 6
12345